Innovations in Treating Vitiligo and Leukoderma

‍

In this illuminating presentation filmed at Aerolase's prestigious The Art of Diversity for Skin Health conference, Cheryl Burgess, MD, takes center stage to address the pressing concerns of medical professionals seeking advancements in Vitiligo and Leukoderma treatment. Focused on enhancing patient care, the discussion revolves around the groundbreaking capabilities of Aerolase's Exci308 energy-based device, offering an optimal solution for relieving and eliminating these skin conditions. Dr. Burgess, a distinguished expert in the field, guides fellow healthcare practitioners through innovative approaches, emphasizing the potential for transformative outcomes in the realm of Vitiligo and Leukoderma management.

The Art of Diversity for Skin Health Conference is an exclusive event that brings together healthcare professionals from diverse backgrounds and locations to discuss the advancements in laser technology for skin health. With a focus on promoting inclusivity and addressing skin health issues faced by underrepresented communities, this event is a unique opportunity to learn about the latest breakthroughs in laser technology and their applications in dermatology for skin of color.

Presented by Cheryl Burgess, MD, FAAD

Founder, medical director, and president of the Center for Dermatology and Dermatologic Surgery, PC in Washington, DC. Dr. Burgess is a nationally and internationally recognized expert for advanced technology in non-invasive aesthetic procedures. Currently serving on the Board of Directors for the American Academy of Dermatology.